Form 4: Atara Biotherapeutics Executive Sells Shares to Cover Tax Obligations

EVP and Chief Legal Officer of Atara Biotherapeutics, Amar Murugan, sold shares to cover tax withholding obligations related to vested restricted stock units.

Summary

• Amar Murugan, EVP and Chief Legal Officer of Atara Biotherapeutics, sold shares of common stock on August 16, 2024.
• The sales were executed to satisfy tax withholding obligations related to the vesting of previously granted restricted stock units.
• A total of 1,158 shares were sold at weighted average prices of $6.629, $6.63, and $6.631.
• Following the transactions, Murugan directly owns 26,827 shares of Atara Biotherapeutics common stock.
• This amount includes 4,507 shares purchased under the Issuer's Employee Stock Purchase Plan on May 31, 2024, and reflects the 1:25 reverse stock split effected by the Issuer on June 20, 2024.

Sentiment

Score: 5

Explanation: The document reflects a routine transaction (stock sale for tax obligations) and doesn't inherently indicate positive or negative sentiment regarding the company's prospects.

Industry Context

Executive stock sales are a common occurrence, particularly to cover tax obligations related to equity compensation. The filing provides transparency into insider transactions, allowing investors to monitor executive sentiment and potential alignment with company performance.

Stakeholder Impact

• The stock sale has a minimal impact on shareholders as it is a small percentage of the outstanding shares.
• The transaction ensures the executive remains compliant with tax obligations related to their compensation.

Key Dates